Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The net worth of the market share of the chromatography resin industry is predicted to grow from US$ 1.4 billion in 2023 to over US$ 2.8 billion by 2033. The market for chromatography resin is anticipated to register a CAGR of 7.5% from 2023 to 2033. Market growth is primarily driven by an increase in biosimilar demand and a growing amount of pharmaceutical & biopharmaceutical Research and Development (R&D) activities.
Over the last decade, chromatography resins have been in high demand for drug discovery applications due to increasing pharmaceutical and biopharmaceutical R&D activities. There is enormous demand for biosimilars in the Asia Pacific and they are expected to grow dramatically in the United States and Japan. An increase in R&D spending is expected to increase the demand for chromatography, which forms an integral part of pharmaceutical R&D activities.
Moreover, most pharmaceutical companies are based in the United States, it is expected that this country may remain a major consumer of this industry. Also, the USA has seen strong growth as a result of government spending on research and development. As disposable income rises, essential and preventive healthcare services are likely to be more affordable, thereby increasing product consumption.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Chromatography Resin Market Value (2023) | US$ 1.4 billion |
Chromatography Resin Market Expected Value (2033) | US$ 2.8 billion |
Chromatography Resin Market Projected CAGR (2023 to 2033) | 7.5% |
The rising prevalence of non-communicable diseases and the adoption of chromatography resins for the separation of bio-similar and bio-molecules are some of the key drivers propelling the market growth.
According to the ESOMAR-certified consulting firm Future Market Insights, the global chromatography resin market is poised to expand at a steady growth rate of around 7.5% CAGR during the forecast period of 2023 and 2033.
Surging demand for monoclonal antibody production and expansion of the bio-pharmaceutical industry across developed countries will improve the demand for chromatography resins. Spurred by this, chromatography resins sales will surpass a value of US$ 2.8 billion in 2033.
Subsequently, increased funding and advancements in research in genomics, the adoption of chromatography resin technology, and the separation of chiral compounds are anticipated to accelerate the growth.
Historical CAGR | 9.6% |
---|---|
Historical Market Value (2022) | US$ 1.2 billion |
Forecast CAGR | 7.5% |
Chromatography Resin Market:
Differentiating Aspects | Chromatography Resin Market |
---|---|
CAGR (2023 to 2033) | 7.5% |
Market Valuation in 2023 | US$ 1.4 billion |
Projected Market Value in 2033 | US$ 2.8 billion |
Growth Factors | Advances in chromatography technologies for separating and purifying complex biomolecules. |
Opportunities | Pharmaceutical and omics researchers are increasingly relying on chromatography for research. |
Key Trends | With agarose matrix as a matrix, Fabs, dAbs, and single-chain fragment variable (scFv) antibody fragments can be captured. |
Mixed Mode Chromatography Resin:
Differentiating Aspects | Mixed Mode Chromatography Resin |
---|---|
CAGR (2023 to 2033) | 7.1% |
Market Valuation in 2023 | US 113.8 million |
Projected Market Value in 2033 | US$ 226 million |
Growth Factors | Leading pharmaceutical companies are developing drugs for diseases such as Ebola, Zika, and H1N1 through drug discovery processes. |
Opportunities | For intermediate purification and polishing in purification protocols/processes, mixed-mode chromatography is advantageous. |
Key Trends | Manufacturers and researchers are becoming more numerous. |
Glutathione Resin Market:
Differentiating Aspects | Glutathione Resin Market |
---|---|
CAGR (2023 to 2033) | 8.4% |
Market Valuation in 2023 | US$ 520 million |
Projected Market Value in 2033 | US$ 1164.25 million |
Growth Factors | Rising production of pharmaceutical drugs as well as vaccines coupled with a growing number of R & D activities. |
Opportunities | Research organizations and players are undertaking initiatives to design and offer more innovative as well as productive solutions. |
Key Trends | Growing demand for affinity chromatography techniques in vaccine and drug development research and development. |
How will Technological Advancements & Demand for Biosimilar Drive Growth?
The rapid adoption of chromatography resin technology within research laboratories and biopharmaceutical companies is extensively focusing on the incorporation of advanced technology is spurring the growth.
Advancements in chromatography technologies for the separation & purification of complex biomolecules and bio-substances will boost the demand for advanced chromatography resin across the USA, Germany, the United Kingdom, and China.
Demand for cost-effective technology for the separation and purification of isomers, enantiomers, and other active pharmaceutical ingredients across Germany is fueling the growth during the forecast period.
Also, increasing the use of chromatography for the bio-separation techniques used in the manufacturing of biosimilar antibodies is improving the adoption of chromatography resins. Rising demand for biosimilars is projected to improve the use of chromatography resins throughout the forecast period.
Presently available biosimilars are utilized for cancer, rheumatoid arthritis, infectious disorders, psoriasis, anemia, post-menopausal osteoporosis, type-1 and type-2 diabetes, and hormonal disorders treatments.
These applications of biosimilars have increased the usage of chromatography resins in the manufacturing and development of economic drugs. These factors are expected to bolster market growth over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Stringent Regulatory Policies to Curb the Chromatography Resin Market Growth
Strict norms implemented by the regulatory bodies, such as USA Food and Drug Administration and the European Commission, for new products such as chromatography resins and columns for analysis & diagnostic purposes are likely to impede the market growth.
Stringent regulations combined with the availability of alternatives to chromatography resin such as ion-exchange resin, Nuvia S, proposed by the industry giant Bio-Rad, are likely to hinder the demand of the chromatography resin market.
The high cost of the adoption and use of chromatography resin technologies is another factor hampering the market growth. Higher selling prices and repeated use of chromatography to lower the manufacturing cost is affecting the quality, which in turn is obstructing the growth.
Further, many manufacturing companies prefer using smaller protein A columns instead of larger protein A columns to reduce the manufacturing cost by repeating cycles for the use of a single batch of monoclonal antibodies (MAbs). This is expected to negatively affect the demand.
How is the Demand for Chromatography Resin Driven by Drug Development and Omics Research?
The separation technique of chromatography is the most versatile technique available. It is critical to separate closely related compounds in the early stages of drug discovery to identify them and ensure their purity. Chromatography techniques are widely used for these purposes.
In addition to separating, purifying, and analyzing raw materials, chromatography instruments can also be used for extracting Active Pharmaceutical Ingredients (APIs), and excipients.
Thus, the growing demand for high-quality drugs and the implementation of stringent government initiatives are increasing the demand for chromatography resin in several countries.
Segment | Top Product Type |
---|---|
Attributes | Synthetic Chromatography |
Details (CAGR) | 7% |
Historical CAGR | 9.7% |
Segment | Top Technology |
---|---|
Attributes | Affinity Chromatography |
Details (CAGR) | 8.2% |
Historical CAGR | 10% |
Segment | Top End-user Type |
---|---|
Attributes | Biopharmaceutical Companies |
Details (CAGR) | 11.2% |
Historical CAGR | 16% |
In terms of product type, the market is bifurcated into native chromatography resins and synthetic chromatography resins. As per the FMI’s analysis, synthetic chromatography resin is preferred over native and it is forecast to exhibit growth at over 7% CAGR during the forecast period.
In biotechnological analytical experiments, when the resins are exposed to adverse and extreme conditions of pH and pressure, synthetic chromatic resins are more suitable than native chromatography resins.
Also, increasing demand for synthetic chromatography resins from biopharmaceutical companies will accelerate growth in the segment. Driven by these factors, the demand for synthetic chromatography resins will remain high during the forecast period.
Revenue generated from sales of native chromatography resins will remain low in the global market during the forecast period.
Based on the technology type, the market is sub-segmented into affinity chromatography, anion exchange chromatography, cation exchange chromatography, size exclusion, and hydrophobic interaction.
As per the FMI’s analysis, affinity chromatography is anticipated to be the most used technology in the market. Revenue generated from the sales of affinity chromatography technology is anticipated to surpass the valuation of approx. US$ 681 million by 2031.
As this technology offers high selectivity, capacity, and resolution in most protein purification schemes, affinity chromatography technology is expected to gain immense popularity over the coming years.
Affinity chromatography technology has the advantage of utilizing a protein’s biological function or structure for purification, which makes this technology simple and time-effective as compared to the other technologies.
Also, increasing the application of this technology in the separation of the mixture of compounds, removal of impurities in the purification process, enzyme assays, and other applications will improve the adoption of this technology among end users.
Biopharmaceutical companies are expected to post substantial gains during the forecast period. They are anticipated to remain the largest end-user of chromatography resins across the globe, followed by academic institutes.
Owing to the increasing research & development activities for the development and trials of chromatography resins, biopharmaceutical companies are investing heavily, generating their revenues.
Increasing the application of chromatography in the biopharmaceutical industry for separating chiral compounds, drug discovery for non-communicable diseases, and protein purification for drug delivery will positively influence the market demand.
As per the report of the World Health Organization (WHO), around 40 million people die due to non-communicable diseases annually. Among these 81% of people succumb to cardiovascular diseases, respiratory disease, cancer, and diabetes mellitus. According to ‘WHO’, the mortality rate due to these diseases are expected to increase by 17% by 2025.
Acknowledging this burden, governments across the globe are providing funding to encourage research & development (R&D) in biopharmaceutical companies. In addition to this, research undertaken on HIV/AIDS, immunodeficiency disorders, and cancer, technological innovations in biotechnological research, and increasing focus on biopharmaceutical companies are some of the key factors fuelling demand in the market.
Sales of chromatography resins in the biopharmaceutical company segment are set to grow at over 11.2%, to reach a valuation of nearly US$ 950 million in revenue by the end of 2033, opines FMI’s market study.
Region | North America |
---|---|
Country | United States |
Historic CAGR | 10% |
CAGR | 7.9% |
Market Value (2023) | US$ 317.5 million |
Market Value (2033) | US$ 598.6 million |
Region | Europe |
---|---|
Country | United Kingdom |
Historic CAGR | 9.1% |
CAGR | 7.6% |
Market Value (2023) | US$ 37.7 million |
Market Value (2033) | US$ 72.6 million |
Region | Europe |
---|---|
Country | Germany |
Historic CAGR | 9.4% |
CAGR | 7.8% |
Market Value (2023) | US$ 119 million |
Market Value (2033) | US$ 225.9 million |
Region | Asia Pacific |
---|---|
Country | China |
Historic CAGR | 11.3% |
CAGR | 8.7% |
Market Value (2023) | US$ 100.9 million |
Market Value (2033) | US$ 178.9 million |
Region | Asia Pacific |
---|---|
Country | India |
Historic CAGR | 10.2% |
CAGR | 8.3% |
Market Value (2023) | US$ 66.9 million |
Market Value (2033) | US$ 121.5 million |
The chromatography resin market in the USA is expected to remain the largest market share of chromatography resins across North America, with sales anticipated to reach a valuation of approximately US$ 700 million by 2031, as per FMI’s projections.
The strong growth of the therapeutic monoclonal antibody market will be the key driver for chromatography resin sales in this region. Increasing adoption of chromatography resin technologies by various industry giants such as Bio-Rad, Thermo Fisher, and Repligen, will propel the market growth.
Increasing research & development expenditure by biopharmaceutical companies and biotechnology companies will improve the market demand. Ever expanding pharmaceutical industry in The USA and the rising geriatric population with critical diseases will aid the growth.
Advanced chromatography technologies used for food analytics and diagnosing purpose due to the high consumption of chromatography resin in the country is boosting the market demand.
In The USA, according to the Centers for Disease Control, over 100 million people suffer from diabetes, and this number has increased two-fold over the past five years. Due to this, there has been a surge in research & development (R&D) activities across the country for developing advanced drugs.
Well-established R&D infrastructure, private investments, and expansion through increased investment by the government for the adoption of chromatography resin technologies within biotechnological institutes are bolstering growth.
India is expected to be a highly lucrative market across South Asia during the forecast period on the back of rising initiatives by the government regarding the increasing burden of non-communicable diseases, estimates to FMI’s analysis.
According to the Ministry of Health & Family Welfare, the government of India launched the national program for the prevention & control of cancer, diabetes, cardiovascular disease, and stroke (NPCDCS) in 2010.
As per the government’s report, non-communicable diseases (NCD) are estimated for over 60% of all deaths, with around 63 million suffering from immunodeficiency disorders.
Due to the rising prevalence of these diseases, the government implemented the NPCDCS program in 100 districts across 21 states. High funding was provided to the biopharmaceutical companies across the region to conduct research & development activities for the development of economic drugs.
According to the World Health Organization, nearly 5.8 million people die from heart and lung diseases and unaffordable drugs. Around 55 million are estimated to die by 2030 due to non-communicable diseases or the unaffordability of drugs in the country.
Hence, with the implementation of the NPCDCS program and high funding, biosimilar drug manufacturers are developing economic drugs for NCD by adopting affinity chromatography resin technology to develop drugs for NCD.
Increasing adoption of chromatography resin technologies within biopharmaceutical companies and research organizations is improving the market demand.
As per the FMI’s analysis, Asia Pacific excluding Japan is estimated to register the fastest expansion of the chromatography resin market, exhibiting growth at 11.4% CAGR during the forecast period.
According to Robert Koch Institute and World Health Organization, the mortality rates due to non-communicable diseases such as cardiovascular disease, chronic respiratory disease, and cancer, accounted for 80% of deaths across Germany in 2017.
By 2025, it is estimated that non-communicable diseases will account for over 91% of all deaths in the country. Among these, cancer accounts for 26% while around 37% of people will succumb to cardiovascular diseases by 2025.
These estimates are causing a high strain on healthcare professionals, due to which the development of drug delivery and discovery has increased in the region. Also, the heavy presence of biopharmaceutical companies across the country is providing a conducive environment for biosimilar drug manufacturers. Thereby, propelling the growth of chromatography resins.
Also, increasing research & development activity in the research organizations in this region is positively impacting the market demand. Germany is expected to witness exponential growth over the years attributed to the increasing investments by the government in biopharmaceutical research & development.
As per the FMI’s projections, Germany is anticipated to be the most lucrative market across Europe, expanding at an impressive growth rate during the forecast period.
As per the FMI’s analysis, the United Kingdom is anticipated to be the key market for chromatography resins in Europe, followed by Germany. The rising prevalence of non-communicable diseases within the country such as diabetes, cancer, cardiovascular diseases, and neurological disorders is increasing the clinical drug trials across the region.
With this, the adoption of chromatography resins and the application of affinity chromatography resin has increased significantly within biopharmaceutical companies and research institutes, accelerating the market growth over the forecast period.
As per the report of National Statistics of the United Kingdom, around 1 million people in the United Kingdom are diagnosed with neurological conditions and approximately 17 million people are suffering from musculoskeletal problems.
Also, the mortality rate in the United Kingdom due to respiratory diseases, which includes chronic obstructive pulmonary disease, pneumonia, scarring lung disease, and sleep apnoea, is higher than in any other country in Europe.
Non-communicable diseases, in 2025, are estimated to account for over 89% of all deaths across the region, states the World Health Organization in its report of non-communicable diseases.
With the rising cases of critical diseases and burdening mortality rates, the government in the United Kingdom is promoting the antibody therapeutics industry, which is expected to improve the chromatography resin market demand.
Initiatives for formulation & drug delivery are conducted actively coupled with high funding for the biological technology research institutes & biopharmaceutical companies, which is furthering the adoption of chromatography resins in the country.
Stringent regulations laid down by regulatory bodies such as European Medicines Agency (EMA) and European Commission (EC) are likely to impede the growth of the chromatography resin market.
According to this, biologic and biosimilar drug manufacturers are supposed to submit robust data for approval and showcase a product’s efficacy and safety profile. In the future, the highly regulated biosimilar and the biologic sector
Chromatography Resin Market Initiatives: Recent Investments from Well-Known Companies in Start-ups
Several manufacturers are introducing multi-performance variants to expand their product portfolio and attract consumers from various industry verticals. Additionally, they are developing chromatography resins with highly efficient, salt-tolerant, high-resolution anion exchangers that enable unique selectivity, increased product yields, reduced downstream purification costs, and improved separation. There is a significant share of the market owned by Tosoh Corporation. To improve its position in the market, the company actively engages in strategies such as mergers and acquisitions. These strategies are boosting industry competitiveness and improve the company's market position.
In the chromatography resin market, there are both multinational and local players, so it is not a consolidated industry. According to FMI, the global chromatography resin market is dominated by the top 5 key players, accounting for 70% of revenue share in 2021. These companies are Bio-Rad Laboratories, Inc., GE Healthcare, Tosoh Corporation, Merck KGaA, and Thermo Fisher Scientific Inc. GE Healthcare, Thermo Fisher, and Merck have extensive product portfolios, extensive distribution networks, and high levels of operational integration. Chromatography resin manufacturers have invested heavily in R&D, resulting in several novel products that can be used across the previously niche market.
Top Manufacturers of Chromatography Resin and their Recent Developments
Company | Recent Developments and Partnerships |
---|---|
Avantor Inc. | In April 2020, Avantor Inc., a leading global provider of mission-critical products and services to customers in life sciences, advanced technology, and the applied materials industry, announced the launch of a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production. |
Navigo Proteins & Eleva GmbH | In March 2021, Navigo Proteins, a leading protein engineering company, and Eleva GmbH, a global manufacturer of superior biologics derived from its proprietary moss expression system, announced the launch of its successful development of an affinity chromatography resin customized for the efficient purification of human complement-Factor H. |
Attribute | Details |
---|---|
Forecast Period | 2023 To 2033 |
Historical Data Available for | 2018 To 2023 |
Market Analysis | US$ million for Value and MT for Volume |
Key Regions Covered |
|
Key Countries Covered | USA, Canada, Brazil, Mexico, Chile, Peru, Germany, United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
Key Segments Covered |
|
Key Companies Profiled |
|
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The global market of chromatography resin is projected to reach a valuation of US$ 2.8 billion by 2033.
GE Healthcare, and Bio-Rad Laboratories, Inc., are top players in the chromatography resin market.
North America is a lucrative market for chromatography resin and is expected to dominate throughout the forecast period.
The global market of chromatography resin is projected to grow at approximately a CAGR of 7.5%.
1. Executive Summary | Chromatography Resin Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Native 5.3.2. Synthetic 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Technology, 2017 to 2022 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Technology, 2023 to 2033 6.3.1. Affinity Chromatography 6.3.2. Anion Exchange Chromatography 6.3.3. Cation Exchange Chromatography 6.3.4. Size Exclusion Chromatography 6.3.5. Hydrophobic Interaction Chromatography 6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Biopharmaceutical Companies 7.3.2. Clinical Research Organizations 7.3.3. Academic Institutes 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. Asia Pacific excluding Japan (APEJ) 8.3.6. Japan 8.3.7. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Technology 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Technology 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Technology 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Technology 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. The United Kingdom 11.2.1.5. Spain 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Technology 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Technology 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Russia 12.2.1.2. Poland 12.2.1.3. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Technology 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Technology 12.3.4. By End User 12.4. Key Takeaways 13. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. India 13.2.1.3. Australia & New Zealand 13.2.1.4. ASEAN 13.2.1.5. Rest of APEJ 13.2.2. By Product Type 13.2.3. By Technology 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Technology 13.3.4. By End User 13.4. Key Takeaways 14. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.2. By Product Type 14.2.3. By Technology 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Technology 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Rest of MEA 15.2.2. By Product Type 15.2.3. By Technology 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Technology 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. The USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Technology 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Technology 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Technology 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Technology 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Technology 16.5.2.3. By End User 16.6. France 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Technology 16.6.2.3. By End User 16.7. United Kingdom 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Technology 16.7.2.3. By End User 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Technology 16.8.2.3. By End User 16.9. Spain 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Technology 16.9.2.3. By End User 16.10. Russia 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Technology 16.10.2.3. By End User 16.11. Poland 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Technology 16.11.2.3. By End User 16.12. China 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Technology 16.12.2.3. By End User 16.13. India 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Technology 16.13.2.3. By End User 16.14. Australia & New Zealand 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Technology 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Technology 16.15.2.3. By End User 16.16. GCC Countries 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Technology 16.16.2.3. By End User 16.17. South Africa 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Technology 16.17.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Technology 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Agilent Technologies 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Bio-Rad Laboratories 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. GE Healthcare 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Waters Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Expedeon Ltd 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Thermo Fisher Scientific Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Pall Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Merck KGaA 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Perkin Elmer Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Kaneka Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Shimadzu Corporation 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Knauer GmbH 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Tosoh Bioscience 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Avantor Performance Materials Inc. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Mitsubishi Chemical Corporation 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.16. W.R. Grace & Co. 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.17. JSR Micro Inc. 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.18. Life Technology Corporation 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 3: Global Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 4: Global Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 5: North America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 6: North America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 7: North America Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 8: North America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 9: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 10: Latin America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 11: Latin America Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 12: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 13: Western Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 14: Western Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 15: Western Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 16: Western Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 17: Eastern Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 18: Eastern Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 19: Eastern Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 20: Eastern Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 21: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 22: APEJ Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 23: APEJ Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 24: APEJ Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 25: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 26: Japan Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 27: Japan Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 28: Japan Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 29: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 30: MEA Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 31: MEA Market Value (US$ million) Forecast by Technology, 2017 to 2033 Table 32: MEA Market Value (US$ million) Forecast by End User, 2017 to 2033
Figure 1: Global Market Value (US$ million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ million) by Technology, 2023 to 2033 Figure 3: Global Market Value (US$ million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ million) Analysis by Region, 2017 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 11: Global Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 14: Global Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Technology, 2023 to 2033 Figure 19: Global Market Attractiveness by End User, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 22: North America Market Value (US$ million) by Technology, 2023 to 2033 Figure 23: North America Market Value (US$ million) by End User, 2023 to 2033 Figure 24: North America Market Value (US$ million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 31: North America Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 34: North America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Technology, 2023 to 2033 Figure 39: North America Market Attractiveness by End User, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ million) by Technology, 2023 to 2033 Figure 43: Latin America Market Value (US$ million) by End User, 2023 to 2033 Figure 44: Latin America Market Value (US$ million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Technology, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Market Value (US$ million) by Product Type, 2023 to 2033 Figure 62: Western Market Value (US$ million) by Technology, 2023 to 2033 Figure 63: Western Market Value (US$ million) by End User, 2023 to 2033 Figure 64: Western Market Value (US$ million) by Country, 2023 to 2033 Figure 65: Western Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 66: Western Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 69: Western Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 70: Western Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 71: Western Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 72: Western Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 73: Western Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 74: Western Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 75: Western Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 76: Western Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 77: Western Market Attractiveness by Product Type, 2023 to 2033 Figure 78: Western Market Attractiveness by Technology, 2023 to 2033 Figure 79: Western Market Attractiveness by End User, 2023 to 2033 Figure 80: Western Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Market Value (US$ million) by Product Type, 2023 to 2033 Figure 82: Eastern Market Value (US$ million) by Technology, 2023 to 2033 Figure 83: Eastern Market Value (US$ million) by End User, 2023 to 2033 Figure 84: Eastern Market Value (US$ million) by Country, 2023 to 2033 Figure 85: Eastern Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 86: Eastern Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 89: Eastern Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 90: Eastern Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 91: Eastern Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 92: Eastern Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 93: Eastern Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 94: Eastern Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 95: Eastern Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 96: Eastern Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 97: Eastern Market Attractiveness by Product Type, 2023 to 2033 Figure 98: Eastern Market Attractiveness by Technology, 2023 to 2033 Figure 99: Eastern Market Attractiveness by End User, 2023 to 2033 Figure 100: Eastern Market Attractiveness by Country, 2023 to 2033 Figure 101: APEJ Market Value (US$ million) by Product Type, 2023 to 2033 Figure 102: APEJ Market Value (US$ million) by Technology, 2023 to 2033 Figure 103: APEJ Market Value (US$ million) by End User, 2023 to 2033 Figure 104: APEJ Market Value (US$ million) by Country, 2023 to 2033 Figure 105: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 106: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: APEJ Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 109: APEJ Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 110: APEJ Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 111: APEJ Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 112: APEJ Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 113: APEJ Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 114: APEJ Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 115: APEJ Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: APEJ Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: APEJ Market Attractiveness by Product Type, 2023 to 2033 Figure 118: APEJ Market Attractiveness by Technology, 2023 to 2033 Figure 119: APEJ Market Attractiveness by End User, 2023 to 2033 Figure 120: APEJ Market Attractiveness by Country, 2023 to 2033 Figure 121: Japan Market Value (US$ million) by Product Type, 2023 to 2033 Figure 122: Japan Market Value (US$ million) by Technology, 2023 to 2033 Figure 123: Japan Market Value (US$ million) by End User, 2023 to 2033 Figure 124: Japan Market Value (US$ million) by Country, 2023 to 2033 Figure 125: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 126: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Japan Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 129: Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 130: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 131: Japan Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 132: Japan Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 133: Japan Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 134: Japan Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 135: Japan Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 136: Japan Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 137: Japan Market Attractiveness by Product Type, 2023 to 2033 Figure 138: Japan Market Attractiveness by Technology, 2023 to 2033 Figure 139: Japan Market Attractiveness by End User, 2023 to 2033 Figure 140: Japan Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ million) by Product Type, 2023 to 2033 Figure 142: MEA Market Value (US$ million) by Technology, 2023 to 2033 Figure 143: MEA Market Value (US$ million) by End User, 2023 to 2033 Figure 144: MEA Market Value (US$ million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 151: MEA Market Value (US$ million) Analysis by Technology, 2017 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 154: MEA Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 157: MEA Market Attractiveness by Product Type, 2023 to 2033 Figure 158: MEA Market Attractiveness by Technology, 2023 to 2033 Figure 159: MEA Market Attractiveness by End User, 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports